Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconSGENSeagen$43.15bnn/an/a
us flag iconIQVIqvia Holdings$37.58bn28.79n/a
us flag iconINSMInsmed$37.29bnn/an/a
us flag iconBNTXBioNTech SE$22.24bnn/an/a
us flag iconEXASExact Sciences$19.32bnn/an/a
us flag iconMEDPMedpace Holdings$15.97bn39.75n/a
us flag iconRVMDRevolution Medicines$15.23bnn/an/a
us flag iconMDGLMadrigal Pharmaceuticals$13.42bnn/an/a
us flag iconICLRIcon$13.27bn17.11n/a
us flag iconSMMTSummit Therapeutics$13.27bnn/an/a
us flag iconIONSIonis Pharmaceuticals$12.89bnn/an/a
us flag iconKRTXKaruna Therapeutics$12.58bnn/an/a
us flag iconASNDAscendis Pharma A/S$12.34bnn/an/a
us flag iconEXELExelixis$11.88bn18.23n/a
us flag iconTEMTempus AI$11.47bnn/an/a
us flag iconRGCRegencell Bioscience Holdings$9.80bnn/an/a
us flag iconCRLCharles River Laboratories International$9.70bn71.28n/a
us flag iconRXDXPrometheus Biosciences$9.56bnn/an/a
us flag iconARWRArrowhead Pharmaceuticals$9.26bnn/an/a
us flag iconTECHBIO-TECHNE$9.08bn50.70.55%